We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+13.5%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$46.4B
AUM Growth
+$5.43B
Cap. Flow
+$392M
Cap. Flow %
0.84%
Top 10 Hldgs %
27.02%
Holding
3,987
New
232
Increased
1,371
Reduced
1,431
Closed
185

Sector Composition

Rank Sector Weight
1 Technology 13.46%
2 Financials 8.89%
3 Healthcare 8.8%
4 Industrials 8.29%
5 Consumer Staples 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBIT icon
3276
XBiotech
XBIT
$69.2M
$8K ﹤0.01%
520
ITCI
3277
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8K ﹤0.01%
266
+42
+19% +$1.1K
FBMS
3278
DELISTED
The First Bancshares, Inc.
FBMS
$8K ﹤0.01%
271
SYRS
3279
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$8K ﹤0.01%
73
+33
+83% +$3.01K
SAVE
3280
DELISTED
Spirit Airlines, Inc.
SAVE
$8K ﹤0.01%
336
-533
-61% -$11K
WPS
3281
DELISTED
iShares International Developed Property ETF
WPS
$8K ﹤0.01%
222
WIRE
3282
DELISTED
Encore Wire Corp
WIRE
$8K ﹤0.01%
139
+52
+60% +$2.69K
NGM
3283
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$8K ﹤0.01%
+270
New +$5.91K
CBAY
3284
DELISTED
Cymabay Therapeutics
CBAY
$8K ﹤0.01%
+1,333
New +$10.1K
SCU
3285
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$8K ﹤0.01%
500
ATRS
3286
DELISTED
Antares Pharma, Inc.
ATRS
$8K ﹤0.01%
1,990
TBIO
3287
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$8K ﹤0.01%
+454
New +$8.13K
BFT
3288
DELISTED
Foley Trasimene Acquisition Corp. II
BFT
$8K ﹤0.01%
+505
New +$5.76K
BLPH
3289
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$8K ﹤0.01%
1,221
RESI
3290
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$8K ﹤0.01%
+479
New +$6.64K
ADAP
3291
DELISTED
Adaptimmune Therapeutics
ADAP
$7K ﹤0.01%
1,436
-471
-25% -$2.56K
ALLO icon
3292
Allogene Therapeutics
ALLO
$601M
$7K ﹤0.01%
297
+247
+494% +$8.05K
AMRC icon
3293
Ameresco
AMRC
$1.15B
$7K ﹤0.01%
124
+10
+9% +$431
ATEX icon
3294
Anterix
ATEX
$1.83B
$7K ﹤0.01%
183
+59
+48% +$1.94K
BHR
3295
Braemar Hotels & Resorts
BHR
$153M
$7K ﹤0.01%
1,556
CAC icon
3296
Camden National
CAC
$924M
$7K ﹤0.01%
192
-47
-20% -$1.62K
CBZ icon
3297
CBIZ
CBZ
$2.29B
$7K ﹤0.01%
263
+4
+2% +$98
CWK icon
3298
Cushman & Wakefield Ltd
CWK
$2.98B
$7K ﹤0.01%
474
+393
+485% +$5.46K
EIG icon
3299
Employers Holdings
EIG
$908M
$7K ﹤0.01%
207
-1,069
-84% -$34.5K
EZM icon
3300
WisdomTree US MidCap Fund
EZM
$937M
$7K ﹤0.01%
168
-1,620
-91% -$64.3K

Similar funds

US Bancorp's Q4 2020 Portfolio in Review

As of Q4 2020, US Bancorp held 3,987 positions worth $46.4B, up 13% from $41B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

US Bancorp's Q4 2020 filing shows 232 new, 1,371 increased, 1,431 reduced and 185 closed positions. Its largest new stake was iShares Russell Top 200 Growth ETF: 29,787 shares worth $3.96M. The largest sale was Invesco QQQ Trust, an estimated $104M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • US Bancorp's largest Q4 2020 buy was iShares Russell Top 200 Growth ETF: 29,787 shares worth $3.96M.
  • US Bancorp added most to iShares National Muni Bond ETF in Q4 2020, an estimated $137M increase.
  • US Bancorp's biggest Q4 2020 reduction was Invesco QQQ Trust, cutting an estimated $104M.
  • US Bancorp fully exited iShares iBonds Dec 2020 Term Corporate ETF in Q4 2020, selling an estimated $40.2M.
  • US Bancorp's ten largest holdings make up 27% of its $46.4B portfolio in Q4 2020.
  • US Bancorp opened 232 new positions and closed 185 in Q4 2020.
  • US Bancorp's portfolio value rose 13% quarter-over-quarter to $46.4B.

Based on US Bancorp's 13F filing for Q4 2020, filed 4 Feb 2021.